Back to Journals » OncoTargets and Therapy » Volume 7

FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping

Total article views   HTML views PDF downloads Totals
11,020 Dovepress* 9,697+ 1,288 10,985
PubMed Central* 1,323 494 1,817
Totals 11,020 1,782 12,802
*Since 21 November 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar